Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-02-14 Sale |
2022-02-14 9:10 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Voliotis Dimitris SVP, Clinical Development |
601 | $50.23 | $30,188 | 40,212 (Direct) |
View |
| 2022-01-18 Sale |
2022-01-20 7:15 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Voliotis Dimitris SVP, Clinical Development |
30,000 | $61.36 | $1,840,745 | 411,097 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-10 Option Award |
2022-02-14 9:10 pm |
N/A 2032-02-09 |
Zentalis Pharmaceuticals Inc. | ZNTL | Voliotis Dimitris SVP, Clinical Development |
34,563 | $0 | 40,212 (Direct) |
View |
| 2022-01-18 Exercise |
2022-01-20 7:15 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Voliotis Dimitris SVP, Clinical Development |
30,000 | $18 | 411,097 (Direct) |
View |
| 2022-01-18 Exercise |
2022-01-20 7:15 pm |
N/A 2030-03-25 |
Zentalis Pharmaceuticals Inc. | ZNTL | Voliotis Dimitris SVP, Clinical Development |
30,000 | $0 | 411,097 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 7:01 pm |
N/A 2031-02-10 |
Zentalis Pharmaceuticals Inc. | ZNTL | Voliotis Dimitris SVP, Clinical Development |
25,000 | $0 | 25,000 (Direct) |
View |